Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

RTOG Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.rtog.org

Clinical Trials

Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery

Phase 2

Completed

Conditions: Gastric Cancer
Esophageal Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2015-11-17

Lead Sponsor: Radiation Therapy Oncology Group

Registration Number: NCT00011960

Locations: 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Mobile Infirmary Medical Center, Mobile, Alabama, United States
🇺🇸
Providence Alaska Medical Center, Anchorage, Alaska, United States

and more 66 locations

Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme

Phase 1

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2003-01-27

Last Posted Date: 2015-11-17

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 40

Registration Number: NCT00003417

Locations: 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States
🇺🇸
Huntsville Hospital System, Huntsville, Alabama, United States

and more 234 locations

Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord

Phase 3

Completed

Conditions: Head and Neck Cancer

Interventions: Radiation: radiation therapy

First Posted Date: 2003-01-27

Last Posted Date: 2017-01-04

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 250

Registration Number: NCT00002727

Locations: 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States
🇺🇸
Huntsville Hospital System, Huntsville, Alabama, United States

and more 234 locations

Radiation Therapy Followed by Bleomycin in Treating Adult Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Phase 2

Terminated

Conditions: Brain and Central Nervous System Tumors

Interventions: Biological: bleomycin
Device: Ommaya reservoir
Radiation: radiation therapy

First Posted Date: 2003-01-27

Last Posted Date: 2020-10-26

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 19

Registration Number: NCT00006916

Locations: 🇺🇸
Foundation for Cancer Research and Education, Phoenix, Arizona, United States
🇺🇸
Markey Cancer Center at University of Kentucky Chandler Medical Center, Lexington, Kentucky, United States
🇺🇸
Methodist Hospital Cancer Center at Nebraska Methodist Hospital - Omaha, Omaha, Nebraska, United States

and more 10 locations

Radiation Therapy in Treating Patients With Stage II Prostate Cancer

Phase 3

Completed

Conditions: Prostate Cancer

Interventions: Radiation: 70.2 Gy 3D-CRT/IMRT
Radiation: 79.2 Gy 3D-CRT/IMRT

First Posted Date: 2003-01-27

Last Posted Date: 2023-01-18

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 1534

Registration Number: NCT00033631

Locations: 🇺🇸
Veterans Affairs Medical Center - Long Beach, Long Beach, California, United States
🇺🇸
Radiological Associates of Sacramento Medical Group, Incorporated, Sacramento, California, United States
🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States

and more 83 locations

Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer

Phase 1

Completed

Conditions: Lung Cancer

Interventions: Drug: celecoxib
Radiation: radiation therapy

First Posted Date: 2003-01-27

Last Posted Date: 2015-11-17

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 21

Registration Number: NCT00046839

Locations: 🇺🇸
Memorial Hospital Cancer Center, Colorado Springs, Colorado, United States
🇺🇸
University of Florida Shands Cancer Center, Gainesville, Florida, United States
🇺🇸
Baptist Cancer Institute - Jacksonville, Jacksonville, Florida, United States

and more 41 locations

Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer

Phase 1

Completed

Conditions: Cervical Cancer

First Posted Date: 2003-01-27

Last Posted Date: 2013-11-19

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 84

Registration Number: NCT00023660

Locations: 🇺🇸
Mobile Infirmary Medical Center, Mobile, Alabama, United States
🇺🇸
Foundation for Cancer Research and Education, Phoenix, Arizona, United States
🇺🇸
Mills-Peninsula Health Services, Burlingame, California, United States

and more 33 locations

Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy

Phase 3

Completed

Conditions: Prostate Cancer

Interventions: Drug: bicalutamide
Drug: placebo
Radiation: radiation therapy

First Posted Date: 2003-01-27

Last Posted Date: 2022-06-15

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 840

Registration Number: NCT00002874

Locations: 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Comprehensive Cancer Institute of Huntsville, Huntsville, Alabama, United States
🇺🇸
Huntsville Hospital System, Huntsville, Alabama, United States

and more 237 locations

Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Phase 3

Completed

Conditions: Prostate Cancer

Interventions: Drug: Casodex
Drug: Eulexin
Drug: LHRH agonist
Radiation: radiation therapy

First Posted Date: 2003-01-27

Last Posted Date: 2022-06-15

Lead Sponsor: Radiation Therapy Oncology Group

Target Recruit Count: 1579

Registration Number: NCT00005044

Locations: 🇺🇸
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸
Comprehensive Cancer Institute, Huntsville, Alabama, United States
🇺🇸
Huntsville Hospital, Huntsville, Alabama, United States

and more 258 locations

Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer

Phase 1

Completed

Conditions: Head and Neck Cancer
Radiation Toxicity

First Posted Date: 2003-01-27

Last Posted Date: 2020-10-22

Lead Sponsor: Radiation Therapy Oncology Group

Registration Number: NCT00006360

Locations: 🇺🇸
Foundation for Cancer Research and Education, Phoenix, Arizona, United States
🇺🇸
UCSF Comprehensive Cancer Center, San Francisco, California, United States
🇺🇸
University of Florida Shands Cancer Center, Gainesville, Florida, United States

and more 15 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy